The anti-depressant Prozac may slow down the development of multiple sclerosis, according to a study of 38 patients by researchers at Groningen University.
The findings are reported in a British Medical Journal publication on Thursday.
Half the patients on the trial were given a placebo, the rest Prozac. At the end of the 24-week test period, two-thirds of those given Prozac had not developed any new brain lesions, compared with 25% of those not taking the drug.
One million people worldwide suffer from MS which has no cure. The researchers say the results are enough to merit further research.
Thank you for donating to DutchNews.nl.
We could not provide the Dutch News service, and keep it free of charge, without the generous support of our readers. Your donations allow us to report on issues you tell us matter, and provide you with a summary of the most important Dutch news each day.Make a donation